Asgari, vitamin D sufficiency study: 73% lower mortality [p=0.03] and 66% lower progression [p=0.02] https://c19p.org/asgari
copied to clipboard
Vitamin D Insufficiency in Disease Severity and Prognosis of the Patients With SARS Corona Virus-2 Infection
et al., Acta Medica Iranica, doi:10.18502/acta.v59i11.7779
Retrospective 98 moderate/severe hospitalized COVID-19+ patients in Iran, showing significantly increased risk of mortality and severity with vitamin D deficiency. IR.AJAUMS.REC.1399.060.
|
risk of death, 72.5% lower, OR 0.27, p = 0.03, cutoff 25ng/mL, adjusted per study, RR approximated with OR.
|
|
risk of progression, 65.6% lower, OR 0.34, p = 0.02, cutoff 25ng/mL, adjusted per study, RR approximated with OR.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Asgari et al., 11/21/2021, retrospective, Iran, Middle East, peer-reviewed, 6 authors, study period 21 May, 2020 - 4 September, 2020.
Contact:
allahyarisam@yahoo.com.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.